Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Be3b714e8787e412917979552e83c636c> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Be3b714e8787e412917979552e83c636c NCIT_P378 "NCI" @default.
- Be3b714e8787e412917979552e83c636c type Axiom @default.
- Be3b714e8787e412917979552e83c636c annotatedProperty IAO_0000115 @default.
- Be3b714e8787e412917979552e83c636c annotatedSource NCIT_C189670 @default.
- Be3b714e8787e412917979552e83c636c annotatedTarget "A regimen consisting of lenalidomide and obinutuzumab followed by obinutuzumab that may be used in the treatment of some forms of non-Hodgkin's lymphoma (NHL), including follicular lymphoma, gastric and nongastric, noncutaneous mucosa-associated lymphoid tissue (MALT) lymphoma, and nodal and splenic marginal zone lymphoma." @default.